Adherium Limited (ASX.ADR) is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Adherium’s Hailie® sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and COPD, and reduce direct and indirect healthcare costs. Together with our strategic partners, we are developing new generation technology and working to deliver value to payers and providers, while maximizing the positive reimbursement environment with remote patient monitoring (RPM) payments now in place. Adherium’s Hailie® digital solution comprises patented sensors and proprietary algorithms that track medication delivery, capturing data for clinicians and generating auditable reimbursement reports for payers and providers. • Most clinical evidence of any digital respiratory monitor (>85 studies involving 13,000 patients) • Clinically proven to improve adherence and outcomes • >170,000 devices sold in 30 countries • Widest US inhaler market coverage • Funded technology upgrade will access US reimbursement